Results 61 to 70 of about 48,270 (163)

Characterization of health care utilization in patients receiving implantable cardioverter-defibrillator therapies: An analysis of the managed ventricular pacing trial. [PDF]

, 2017
BACKGROUND: Implantable cardioverter-defibrillators (ICDs) are effective in terminating lethal arrhythmias, but little is known about the degree of health care utilization (HCU) after ICD therapies.
Cheng, Alan, Ellenbogen, Kenneth A., Nahey, Tara, Peterson, Brett J., Rickard, John, Sherfesee, Lou, Tang, Anthony S., Whellan, David J.   +7 more
core   +1 more source

Inappropriate implantable cardioverter defibrillator shocks—incidence, effect, and implications for driver licensing [PDF]

, 2017
PurposePatients with implantable cardioverter defibrillators (ICDs) have an ongoing risk of sudden incapacitation that may cause traffic accidents. However, there are limited data on the magnitude of this risk after inappropriate ICD therapies.
Abe Haruhiko, Aizawa Yoshifusa, Asai Toru, Fujii Eitaro, Honda Toshihiro, Kasai Atsunobu, Kiyono Ken, Kohno Ritsuko, Kurita Takashi, Manaka Tetsuyuki, Morishima Itsuro, Nitta Takashi, Noda Takashi, Ohmori Hiroya, Okajima Katsunori, Okumura Ken, Ozawa Tomoya, Shimane Akira, Takagi Masahiko, Watanabe Eiichi, Watanabe Shigeyuki, Yamashiro Kohei, 渡邉 重行   +22 more
core   +2 more sources

Implantation of a completely right sided subcutaneous cardioverter-defibrillator in a patient with situs inversus dextrocardia

Indian Pacing and Electrophysiology Journal, 2019
Dextrocardia is a congenital anomaly where the heart is abnormally located in the right hemithorax. In these patients, the implementation of transvenous implantable cardioverter-defibrillator (TV-ICD) can be technically challenging and pose a higher risk
Ariel González-Cordero, Javier López-Puebla, Hilton Franqui-Rivera   +2 more
doaj   +1 more source

Natural History Of Implantable Cardioverter-Defibrillator Implanted At Or After The Age Of 70 Years In A Veteran Population A Single Center Study [PDF]

, 2016
Background: The median age of patients in major Implantable Cardioverter-defibrillator (ICD)trials (MUSTT, MADIT-I, MADIT-II, and SCD-HeFT) was 63-67 years; with only 11% ≥70 years.
Ajam, Samer, Ajam, Tarek, Barmeda, Mamta, Garlie, Jason, Gautam, Sandeep, Jain, Rahul, Kalra, Vikas, Kambur, Thomas, Li, Xiaochen, Miller, John M., Shen, Changyu, Yancey, Kyle W.   +11 more
core   +1 more source

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy [PDF]

, 2005
Hypertrophic cardiomyopathy (HCM) is an important cardiovascular disease with sudden cardiac death as the most devastating presentation. Implantable cardioverter defibrillators (ICD) are the optimal therapy for prevention of sudden death from ventricular
Ghosh, Joydeep, Francis, Johnson, Maron, Barry J.   +2 more
core  

Utilization Rates of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: A 2012 Calculation for a Midwestern Health Referral Region [PDF]

, 2014
Background Utilization rates (URs) for implantable cardioverter-defibrillators (ICDs) for primary prevention of sudden cardiac death (PPSCD) are lacking in the community. Objective To establish the ICD UR in central Indiana.
Buxton, Alfred E., Chen, Peng-Sheng, Groh, William J, Hoang, Allen, Rosenman, Marc, Shen, Changyu, Taylor, Stanley, Zheng, James   +7 more
core   +1 more source

Unusual migration of implantable cardioverter defibrillator that clinically mimicking breast cancer: A case report

Radiology Case Reports
Pacemaker and implantable cardioverter defibrillator migration to the breast are an extremely rare complication. The rarity of this phenomenon and its potential to mimic breast cancer emphasize the importance of reporting such cases.
Abdulwahid M. Salih, Lana RA. Pshtiwan, Halkawt O. Ali, Shko H. Hassan, Vanya I. Jwamer, Shaban Latif, Jihad Ibrahim Hama, Fahmi H. kakamad   +7 more
doaj   +1 more source

Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation [PDF]

, 2014
Background This assessment updates and expands on two previous technology assessments that evaluated implantable cardioverter defibrillators (ICDs) for arrhythmias and cardiac resynchronisation therapy (CRT) for heart failure (HF).
, , , , , , , , , , , , , , , , , , , , , , , , , , Abraham, Abraham, Abraham, Ahmed, Aidelsburger, Al-Khatib, Al-Majed, Anand, Arshad, Auricchio, Banz, Bardy, Berdowski, Bertoldi, Bertoldi, Beshai, Beshai, Biffi, Bigger, Bigger, Bigger, Blomstrom, Boehmer, Bokhari, Bond, Bonow, Bouvy, Briggs, Bristow, Bristow, Bryant, Bunch, Bunch, Buxton, Buxton, Bänsch, Callejo, Calvert, Calvert, Camm, Caro, Caro, Carson, Cazeau, Chan, Chan, Chen, Chugh, Cleland, Cleland, Cleland, Cleland, Cleland, Cleland, Cobb, Connolly, Connolly, Cowie, Cowie, Cunningham, Cunningham, Curnis, Curtis, Deniz, Dewland, Drummond, Dumas, Ellenbogen, Eurich, Ezekowitz, Feingold, Feldman, Filion, Foley, Fox, Fox, Gandjour, Garrigue, Gervais, Ghio, Gohler, Goldberger, Goldberger, Goldenberg, Goldenberg, Goldenberg, Gras, Greenberg, Greenspon, Groeneveld, Hallstrom, Hauser, Heerey, Higgins, Hobbs, Hohnloser, Hohnloser, Holland, Holland, Horlbeck, Huang, Irvine, Kadish, Kadish, Kind, Kirsch, Klein, Kron, Kron, Kuck, Kupersmith, Kuppermann, Lane, Larsen, Larsen, Lau, Leclercq, Lee, Linde, Linde, Linde, Lopshire, Lozano, Madsen, Mark, Mark, McAlister, McDonagh, McGregor, McMurray, Miller-Davis, Mitchell, Moss, Moss, Moss, Moss, Moss, Moss, Mosterd, Mushlin, Myerburg, Nademanee, Namerow, Neyt, Neyt, Nichol, Noyes, Olde, Owens, Owens, O’Brien, O’Brien, Packer, Parkes, Passman, Pedersen, Philips, Piccini, Piccirillo, Pinter, Poggio, Polentini, Pratt, Ribeiro, Ribeiro, Sanders, Sanders, Sanders, Sanders, Saxon, Scarborough, Schaechter, Schaer, Schron, Scott, Scott, Shahar, Sheldon, Sheldon, Siebels, Siebels, Siebels, Solomon, Spotnitz, St John Sutton, Steinbeck, Steinbeck, Stevenson, Strickberger, Tang, Tang, Tappenden, Taylor, Townsend, Tracy, van Rees, Wang, Weiss, Wells, Wijetunga, Wilkoff, Yao, You, Young, Youngquist, Zipes, Zwanziger   +232 more
core   +2 more sources

“Atrial torsades de pointes” Induced by Low-Energy Shock From Implantable-Cardioverter Defibrillator

Indian Pacing and Electrophysiology Journal, 2013
A 58 year-old-patient developed an episode of polymorphic atrial tachycardia which looked like "atrial torsades de pointes" after a 5J shock from implantable cardioverter defibrillator.
Ilknur Can, MD, Venkatakrishna Tholakanahalli, MD, FHRS   +1 more
doaj   +1 more source

Impact of the implantable cardioverter-defibrillator on rehospitalizations [PDF]

, 2017
Patients who survive out-of-hospital ventricular tachycardia or ventricular fibrillation are at risk of sudden cardiac death and often return to hospital after initial discharge.
Fischer, A., Fromer, M., Kappenberger, L., Schlapfer, J., Valenti, R.   +4 more
core